Matthew B Avison

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Venues

Antimicrobial agents and chemotherapy

Applied and environmental microbiology

Infectious diseases and therapy

Global public health

University of Bristol

University of Bristol (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bristol Aug 01 2018

United Kingdom

Professor of Molecular Bacteriology

University of Bristol Aug 01 2017 - Jul 31 2018

United Kingdom

Reader in Molecular Bacteriology

University of Bristol Aug 01 2006 - Aug 01 2017

United Kingdom

Senior Lecturer in Microbiology

University of Bristol Aug 01 2003 - Aug 01 2006

United Kingdom

Lecturer in Microbiology

University of Bristol Aug 01 2000 - Aug 01 2003

United Kingdom

Temporary Lecturer in Biochemistry

University of Bristol Oct 01 1998 - Aug 01 2000

United Kingdom

Research Associate :: Pathology & Microbiology

Education History

University of Bristol Oct 01 1994 - Oct 01 1998

United Kingdom

PHD

University of Bristol Oct 01 1991 - Jul 01 1994

United Kingdom

BSC

Publications

Nour AIhusein, Nutcha Charoenboon, Kantima Wichuwaranan, Kornrawan Poonsawad, Varapon Montrivade, Matthew B Avison, Luechai Sringernyuang, Helen Lambert
The unseen use of antimicrobials: Drivers of human antibiotic use in a community in Thailand and implications for surveillance. Global public health 19 (1) (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy 13 (9) (2024)
Nour AIhusein, Nutcha Charoenboon, Kantima Wichuwaranan, Kornrawan Poonsawad, Varapon Montrivade, Matthew B Avison, Luechai Sringernyuang, Helen Lambert
The unseen use of antimicrobials: Drivers of human antibiotic use in a community in Thailand and implications for surveillance. Global public health 19 (1) (2024)
Oliver Mounsey, Laura Marchetti, Julián Parada, Laura V Alarcón, Florencia Aliverti, Matthew B Avison, Carlos S Ayala, Cristina Ballesteros, Caroline M Best, Judy Bettridge, Andrea Buchamer, Daniel Buldain, Alicia Carranza, Maite Corti Isgro, David Demeritt, Maria Paula Escobar, Lihuel Gortari Castillo, María Jaureguiberry, Mariana F Lucas, L Vanina Madoz, María José Marconi, Nicolás Moiso, Hernán D Nievas, Marco A Ramirez Montes De Oca, Carlos Reding, Kristen K Reyher, Lucy Vass, Sara Williams, José Giraudo, R Luzbel De La Sota, Nora Mestorino, Fabiana A Moredo, Matías Pellegrino
Genomic epidemiology of third-generation cephalosporin-resistant Escherichia coli from Argentinian pig and dairy farms reveals animal-specific patterns of co-resistance and resistance mechanisms. Applied and environmental microbiology (2024)
Oliver Mounsey, Laura Marchetti, Julián Parada, Laura V Alarcón, Florencia Aliverti, Matthew B Avison, Carlos S Ayala, Cristina Ballesteros, Caroline M Best, Judy Bettridge, Andrea Buchamer, Daniel Buldain, Alicia Carranza, Maite Corti Isgro, David Demeritt, Maria Paula Escobar, Lihuel Gortari Castillo, María Jaureguiberry, Mariana F Lucas, L Vanina Madoz, María José Marconi, Nicolás Moiso, Hernán D Nievas, Marco A Ramirez Montes De Oca, Carlos Reding, Kristen K Reyher, Lucy Vass, Sara Williams, José Giraudo, R Luzbel De La Sota, Nora Mestorino, Fabiana A Moredo, Matías Pellegrino
Genomic epidemiology of third-generation cephalosporin-resistant Escherichia coli from Argentinian pig and dairy farms reveals animal-specific patterns of co-resistance and resistance mechanisms. Applied and environmental microbiology (2024)
Punyawee Dulyayankul, Jordan E Sealey, Winnie W Y Lee, Naphat Satapoomin, Carlos Reding, Kate J Heesom, Philip B Williams, Matthew B Avison
Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial agents and chemotherapy (2024)
Punyawee Dulyayangkul, Jordan E Sealey, Winnie W Y Lee, Naphat Satapoomin, Carlos Reding, Kate J Heesom, Philip B Williams, Matthew B Avison
Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial agents and chemotherapy 68 (7) (2024)
Punyawee Dulyayangkul, Jordan E Sealey, Winnie W Y Lee, Naphat Satapoomin, Carlos Reding, Kate J Heesom, Philip B Williams, Matthew B Avison
Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial agents and chemotherapy (2024)
Nour AIhusein, Nutcha Charoenboon, Kantima Wichuwaranan, Kornrawan Poonsawad, Varapon Montrivade, Matthew B Avison, Luechai Sringernyuang, Helen Lambert
The unseen use of antimicrobials: Drivers of human antibiotic use in a community in Thailand and implications for surveillance. Global public health 19 (1) (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy 13 (9) (2024)
Punyawee Dulyayangkul, Jordan E Sealey, Winnie W Y Lee, Naphat Satapoomin, Carlos Reding, Kate J Heesom, Philip B Williams, Matthew B Avison
Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial agents and chemotherapy 68 (7) (2024)
Punyawee Dulyayangkul, Jordan E Sealey, Winnie W Y Lee, Naphat Satapoomin, Carlos Reding, Kate J Heesom, Philip B Williams, Matthew B Avison
Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial agents and chemotherapy 68 (7) (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy 13 (9) (2024)
Punyawee Dulyayangkul, Jordan E Sealey, Winnie W Y Lee, Naphat Satapoomin, Carlos Reding, Kate J Heesom, Philip B Williams, Matthew B Avison
Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial agents and chemotherapy 68 (7) (2024)
Jordan E Sealey, Richard Saunders, Teresa Horspool, Michelle G Barrows, Matthew B Avison
Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo. The Journal of antimicrobial chemotherapy (2023)
Naphat Satapoomin, Punyawee Dulyayangkul, Matthew B Avison
Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam. Antimicrobial agents and chemotherapy 66 (4) (2022)
Jordan E Sealey, Ashley Hammond, Oliver Mounsey, Virginia C Gould, Kristen K Reyher, Matthew B Avison
Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Hannah Schubert, Katy Morley, Emma F Puddy, Robert Arbon, Jacqueline Findlay, Oliver Mounsey, Virginia C Gould, Lucy Vass, Madeleine Evans, Gwen M Rees, David C Barrett, Katy M Turner, Tristan A Cogan, Matthew B Avison, Kristen K Reyher
Reduced Antibacterial Drug Resistance and bla CTX-M β-Lactamase Gene Carriage in Cattle-Associated Escherichia coli at Low Temperatures, at Sites Dominated by Older Animals, and on Pastureland: Implications for Surveillance. Applied and environmental microbiology 87 (6) (2021)
Maryam Alzayn, Punyawee Dulyayangkul, Naphat Satapoomin, Kate J Heesom, Matthew B Avison
OmpF Downregulation Mediated by Sigma E or OmpR Activation Confers Cefalexin Resistance in Escherichia coli in the Absence of Acquired β-Lactamases. Antimicrobial agents and chemotherapy 65 (11) (2021)
Oliver Mounsey, Hannah Schubert, Jacqueline Findlay, Katy Morley, Emma F Puddy, Virginia C Gould, Paul North, Karen E Bowker, O Martin Williams, Philip B Williams, David C Barrett, Tristan A Cogan, Katy M Turner, Alasdair P MacGowan, Kristen K Reyher, Matthew B Avison
Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region. The Journal of antimicrobial chemotherapy 76 (12) (2021)
Andrea Turner, Hannah Schubert, Emma F Puddy, Jordan E Sealey, Virginia C Gould, Tristan A Cogan, Matthew B Avison, Kristen K Reyher
Factors influencing the detection of antibacterial-resistant Escherichia coli in faecal samples from individual cattle. Journal of applied microbiology 132 (4) (2021)
Punyawee Dulyayangkul, Karina Calvopiña, Kate J Heesom, Matthew B Avison
Novel Mechanisms of Efflux-Mediated Levofloxacin Resistance and Reduced Amikacin Susceptibility in Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 65 (1) (2020)
Punyawee Dulyayangkul, Wan Ahmad Kamil Wan Nur Ismah, Edward J A Douglas, Matthew B Avison
Mutation of kvrA Causes OmpK35 and OmpK36 Porin Downregulation and Reduced Meropenem-Vaborbactam Susceptibility in KPC-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 64 (7) (2020)
Punyawee Dulyayangkul, Edward J A Douglas, Filip Lastovka, Matthew B Avison
Resistance to Ceftazidime/Avibactam plus Meropenem/Vaborbactam When Both Are Used Together Is Achieved in Four Steps in Metallo-β-Lactamase-Negative Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 64 (10) (2020)
Ching Hei Phoebe Cheung, Punyawee Dulyayangkul, Kate J Heesom, Matthew B Avison
Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 64 (8) (2020)
Karina Calvopiña, Punyawee Dulyayangkul, Matthew B Avison
Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 64 (2) (2020)
Jacqueline Findlay, Oliver Mounsey, Winnie W Y Lee, Nerissa Newbold, Katy Morley, Hannah Schubert, Virginia C Gould, Tristan A Cogan, Kristen K Reyher, Matthew B Avison
Molecular Epidemiology of Escherichia coli Producing CTX-M and pAmpC β-Lactamases from Dairy Farms Identifies a Dominant Plasmid Encoding CTX-M-32 but No Evidence for Transmission to Humans in the Same Geographical Region. Applied and environmental microbiology 87 (1) (2020)
Yuiko Takebayashi, Emma S Taylor, Sam Whitwam, Matthew B Avison
CreC Sensor Kinase Activation Enhances Growth of Escherichia coli in the Presence of Cephalosporins and Carbapenems. Antimicrobial agents and chemotherapy 63 (11) (2019)
Karina Calvopiña, Punyawee Dulyayangkul, Kate J Heesom, Matthew B Avison
TonB-dependent uptake of β-lactam antibiotics in the opportunistic human pathogen Stenotrophomonas maltophilia. Molecular microbiology 113 (2) (2019)
Karina Calvopiña, Philip Hinchliffe, Jürgen Brem, Kate J Heesom, Samar Johnson, Ricky Cain, Christopher T Lohans, Colin W G Fishwick, Christopher J Schofield, James Spencer, Matthew B Avison
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates. Molecular microbiology 106 (3) (2017)

Matthew B Avison.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew B Avison